LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 82.75 | 84.90 | 667 | 8621 | 0.0774 | 0.3624 | MN20160318_Q02 | E21 |
MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 82.75 | 84.90 | 9517 | 8621 | 1.1039 | 1.0299 | MN20160318_Q02 | E21 |
MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 84.45 | 84.90 | 1940 | 8254 | 0.2350 | 0.6062 | MN20160318_Q02 | E16 |
MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 84.45 | 84.90 | 8031 | 8254 | 0.9729 | 0.9917 | MN20160318_Q02 | E16 |
MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 84.45 | 84.90 | 631 | 8254 | 0.0764 | 0.3550 | MN20160318_Q02 | E21 |
MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 84.45 | 84.90 | 9787 | 8254 | 1.1856 | 1.0522 | MN20160318_Q02 | E21 |
MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 86.16 | 84.90 | 2048 | 8141 | 0.2515 | 0.6218 | MN20160318_Q02 | E16 |
MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 86.16 | 84.90 | 8341 | 8141 | 1.0244 | 1.0074 | MN20160318_Q02 | E16 |
MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 86.16 | 84.90 | 738 | 8141 | 0.0906 | 0.3889 | MN20160318_Q02 | E21 |
MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 86.16 | 84.90 | 10028 | 8141 | 1.2316 | 1.0643 | MN20160318_Q02 | E21 |
MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 87.86 | 84.90 | 2157 | 7680 | 0.2809 | 0.6450 | MN20160318_Q02 | E16 |
MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 87.86 | 84.90 | 8588 | 7680 | 1.1182 | 1.0347 | MN20160318_Q02 | E16 |
MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 87.86 | 84.90 | 663 | 7680 | 0.0863 | 0.3720 | MN20160318_Q02 | E21 |
MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 87.86 | 84.90 | 10321 | 7680 | 1.3438 | 1.0930 | MN20160318_Q02 | E21 |
MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 89.57 | 84.90 | 2165 | 7494 | 0.2889 | 0.6504 | MN20160318_Q02 | E16 |
MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 89.57 | 84.90 | 8884 | 7494 | 1.1854 | 1.0533 | MN20160318_Q02 | E16 |
MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 89.57 | 84.90 | 738 | 7494 | 0.0985 | 0.3973 | MN20160318_Q02 | E21 |
MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 89.57 | 84.90 | 10611 | 7494 | 1.4158 | 1.1105 | MN20160318_Q02 | E21 |
MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 91.27 | 84.90 | 2338 | 7420 | 0.3151 | 0.6721 | MN20160318_Q02 | E16 |
MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 91.27 | 84.90 | 9190 | 7420 | 1.2385 | 1.0674 | MN20160318_Q02 | E16 |
MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 91.27 | 84.90 | 646 | 7420 | 0.0871 | 0.3698 | MN20160318_Q02 | E21 |
MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 91.27 | 84.90 | 10896 | 7420 | 1.4684 | 1.1228 | MN20160318_Q02 | E21 |
MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 92.98 | 84.90 | 2390 | 7257 | 0.3293 | 0.6821 | MN20160318_Q02 | E16 |
MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 92.98 | 84.90 | 9487 | 7257 | 1.3072 | 1.0852 | MN20160318_Q02 | E16 |
MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 92.98 | 84.90 | 541 | 7257 | 0.0745 | 0.3345 | MN20160318_Q02 | E21 |